Management of Diabetes in Developing Countries and Other Resource-Limited Settings
Image For Activity Cover
Availability
On-Demand
Expires on 12/31/2024
Cost
$0.00
Credit Offered
1 AMA PRA Category 1 Credit
1 Participation Credit
  • Course Description
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
In this presentation, we shine a spotlight on the critical issues surrounding the management of diabetes in developing countries and other resource-limited settings. Our primary goal is to explore and understand the unique challenges confronting healthcare providers in these regions as they navigate the complexities of diabetes care. We will delve into the hurdles related to limited resources, access to medications, and diagnostic tools, along with the difficulties of providing comprehensive support to individuals with diabetes under these circumstances. By sharing experiences and insights, we aim to foster a deeper appreciation of the challenges faced by healthcare providers and to encourage discussions around innovative solutions and support systems that can help improve diabetes management in these resource-limited settings.
  • Identify Unique Challenges: To help healthcare providers recognize and understand the distinct challenges of managing diabetes in resource-limited settings, such as limited access to medications and diagnostic tools.
  • Strategies for Resource Optimization: To explore practical strategies and solutions that healthcare providers can employ to optimize available resources and deliver effective diabetes care.
  • Enhance Clinical Competence: To improve the clinical skills and knowledge of healthcare professionals, enabling them to provide quality care and education to individuals with diabetes in resource-limited environments.
  • Promote Collaboration and Strengthen Patient Support: To encourage collaboration and information sharing among healthcare providers, enabling them to learn from one another's experiences and successes in order to continue to offer comprehensive support to individuals with diabetes despite the challenges.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit

The Endocrine Society designates each activity in this course for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Yanira Pagan-Carlo, MD - Moderator
Endocare PR/ Integrated Pathology Labs 
San Juan, Puerto Rico

Abok Ibrahim Ishaya, MBBS, MSC, FWACP, FESPE
University of Jos
Plateau, Nigeria

Marie-Nancy Charles Larco, MD, PhD
FHADIMAC - Haitian Diabetes and Cardiovascular Disease Foundation 
Port-au-Prince, Haiti

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.


The following faculty reported no relevant financial relationships:
  • Abok Ibrahim Ishaya, MBBS, MSC, FWACP, FESPE
  • Marie-Nancy Charles Larco, MD, PhD

The following member who reviewed content for this activity reported relevant financial relationships:

  • Yanira Pagan-Carlo, MD

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By